Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.
Herein, we review evidence supporting a role for Leishmania exosomes during early infection. We suggest a model in which Leishmania secreted microvesicles released into the extracellular milieu deliver effector cargo to host target cells. This cargo mediates immunosuppression and functionally primes host cells for Leishmania invasion. Leishmania ssp. release microvesicles and the amount of vesicle release and the specific protein cargo of the vesicles is sensitive to changes in environmental conditions that mimic infection. Leishmania exosomes influence the phenotype of treated immune cells. For example, wild-type (WT) exosomes attenuate interferon-γ-induced pro-inflammatory cytokine production (TNF-α) by Leishmania-infected monocytes while conversely enhancing production of the anti-inflammatory cytokine IL-10. The Leishmania proteins GP63 and elongation factor-1α (EF-1α) are found in secreted vesicles and are likely important effectors responsible for these changes in phenotype. GP63 and EF-1α access host cell cytosol and activate multiple host protein-tyrosine phosphatases (PTPs). Activation of these PTPs negatively regulates interferon-γ signaling and this prevents effective expression of the macrophage microbicidal arsenal, including TNF-α and nitric oxide. In addition to changing macrophage phenotype, WT vesicles dampen the immune response of monocyte-derived dendritic cells and CD4+ T lymphocytes. This capacity is lost when the protein cargo of the vesicles is modified, specifically when the amount of GP63 and EF-1α in the vesicles is reduced. It appears that exosome delivery of effector proteins results in activation of host PTPs and the negative regulatory effects of the latter creates a pro-parasitic environment. The data suggest that Leishmania exosomes secreted upon initial infection are capable of delivering effector cargo to naïve target cells wherein the cargo primes host cells for infection by interfering with host cell signaling pathways.
Brain Research Center, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Judith Maxwell
JM
Silverman
Neil E
NE
Reiner
D000818:Animals; D055354:Exosomes / Q000382:microbiology / Q000502:physiology* / Q000648:ultrastructure; D006790:Host-Parasite Interactions / Q000276:immunology / Q000502:physiology; D006801:Humans; D007891:Leishmania / Q000276:immunology / Q000472:pathogenicity* / Q000502:physiology / Q000648:ultrastructure; D007896:Leishmaniasis / Q000209:etiology* / Q000276:immunology / Q000469:parasitology; D008666:Metalloendopeptidases / Q000502:physiology; D008954:Models, Biological; D020648:Peptide Elongation Factor 1 / Q000502:physiology; D015800:Protozoan Proteins / Q000502:physiology
D020648:Peptide Elongation Factor 1; D015800:Protozoan Proteins; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania